A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma

NCT00434642 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Carboplatin
DRUG: Gemcitabine
DRUG: Bevacizumab
DRUG: Placebo

Sponsor

Genentech, Inc.